Beryl Drugs Ltd
₹0.00▲ +0.00 (+0.00%)
BERYLDRUGSLTD·NSE·Healthcare
Market Cap
11.20 Cr
PE Ratio
19.60
Volume
—
Day High - Low
—
52W High-Low
27.60 - 15.92
₹0.00▲ +0.00 (+0.00%)
Market Cap11.20 Cr
PE Ratio19.60
Volume—
Day High - Low—
52W High-Low27.60 - 15.92
Beryl Drugs Ltd (BERYLDRUGSLTD): company summary
Beryl Drugs Ltd (BERYLDRUGSLTD) is a micro-cap Healthcare company valued at ₹11 crore operating in Pharmaceuticals on the NSE and BSE.
Beryl Drugs Ltd (BERYLDRUGSLTD) is a micro-cap Healthcare company valued at ₹11 crore operating in Pharmaceuticals on the NSE and BSE.
- Financial performance
- Revenue has been shrinking at -11.2% a year over three years; profit fell 14.6% a year, behind revenue — margins are under pressure. Return on equity is 4.3%.
- Valuation multiples
- The stock trades at 19.6 times earnings, a discount to the Healthcare median of 32.0, 1.24 times book value.
Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Not currently trading — we have seen no trades on NSE or BSE recently. It may be suspended, delisted, or renamed after a corporate action. Not a live price.
DocStoX Score
4.6/10
Weak
Fair Value
Sign in to see
ROE
4.33%
Weak
P/E
19.60x
Fair
Debt / Equity
0.25
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Weak
Price performance
52W₹15.92
₹27.60
DocStoX take
Supported by growth (6.3), but held back by quality (3.6). Scored on 4 of 5 measures.
DocStoX score
Medium confidence4.6
/10
Weak
Quality
Modest
ROE 4.3%
Valuation
Rich
P/E 19.6×
Growth
Steady
Revenue +6.0% 5Y CAGR
Risk
Elevated
D/E 0.25
Momentum
No data
No technical indicators
Scored on 4 of 5 measures — the rest have no data for this company.
At a glance
Market Cap
₹11 Cr
52W High / Low
₹28 / ₹16
Dividend Yield
0.00%
Promoter Holding
27.82%
EPS (TTM)
₹1.14
Book Value
₹19.44
Key highlights
- Small ₹11 cr company — thinner liquidity
0 Positives1 Watchout
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore Beryl Drugs Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Beryl Drugs Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Sun Pharmaceutical Industries LimitedDivi's Laboratories LimitedTorrent Pharmaceuticals LimitedApollo Hospitals Enterprise LimitedZydus Lifesciences LimitedLaurus Labs LimitedCipla LimitedDr. Reddy's Laboratories LimitedAurobindo Pharma LimitedMankind Pharma LimitedLupin LimitedManipal Health Enterprises Limited
Compare Beryl Drugs Ltd with peers
Related tools & concepts
Value Beryl Drugs Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing